Skip to main content

Advertisement

SpringerLink
Log in

Cerebral palsy

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

  • The neurorehabilitation program for cerebral palsy changes over time. During the first 2 years of life, an infant stimulation program with an emphasis on more than just improving motor deficits is emphasized. The importance of involvement of a knowledgeable therapist cannot be overemphasized. Realistic expectations must be articulated firmly. Rather then cautiously attempting to correct a dysfunction that cannot be corrected, the therapist should help the patient develop compensation techniques; the severity of the disability frequently militates against the development of “normal” motor control. Educating the parents about cerebral palsy, showing how positioning can be an effective way of helping the child be mobile, and encouraging parent-child interaction are aspects of an infant stimulation program. The therapist should serve as a coach to the parents, who implement much of the actual treatment on a daily basis at home.

  • From 2 to 5 years of age, rapid growth occurs, and muscle tone will either develop or worsen—the latter leading not only to the development of contracture but also to a decrease in mobility. In developing a program to control this muscle tone, the most important question to be answered is, Can I improve the patient’s function and decrease the patient’s disability by altering muscle tone? It is not uncommon for the real problem preventing the patient from performing certain functions to be lack of motor control or lack of sensation and not the abnormal muscle tone [1].

  • Between 5 and 10 years of age, the child begins to approach adult height. At this time, definitive orthopedic intervention can be considered; as already noted, contracture development occurs as a result of abnormal muscle tone in combination with growth.

  • Finally, as the child approaches the teen years, issues of sitting and hygiene are important considerations, especially in the nonambulatory patient. The problem of pain secondary to spasticity or dystonia must be addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Landau WM: Spasticity: the fable of a neurological demon and the emperor’s new therapy [editorial]. Arch Neurol 1974, 31:217–219.

    PubMed  CAS  Google Scholar 

  2. Nelson KB, Ellenberg IH: Epidemiology of cerebral palsy. Adv Neurol 1978, 19:421–435.

    PubMed  CAS  Google Scholar 

  3. Weiss H, Betts HB: Methods of rehabilitation in children with neuromuscular disorders. Pediatr Clin North Am 1967, 14:1009–1017.

    PubMed  CAS  Google Scholar 

  4. Hagberg B, Hagberg G, Olow I: The changing panorama of cerebral palsy in Sweden. IV. Epidemiological trends 1959–1978. Acta Pediatr Scand 1984, 73:433–440.

    CAS  Google Scholar 

  5. Stanley FJ, English DR: Prevalence of and risk factors for cerebral palsy in a total population cohort of low-birthweight (<2000 g) infants. Dev Med Child Neurol 1986, 28:559–568.

    Article  PubMed  CAS  Google Scholar 

  6. Campbell SK: Quantifying the effects of interventions for movement disorders resulting from cerebral palsy. J Child Neurol 1996, 11(suppl 1):S61-S70.

    PubMed  Google Scholar 

  7. Gisel EG, Patrick J: Identification of children with cerebral palsy unable to maintain a normal nutritional state. Lancet 1988, 1:283–285.

    Article  PubMed  CAS  Google Scholar 

  8. Shapiro BK, Green P, Krick J, et al.: Growth of severely impaired children: neurological versus nutritional factors. Dev Med Child Neurol 1986, 28:729–733.

    Article  PubMed  CAS  Google Scholar 

  9. O’Grady RS, Nishimura DM, Kohn JG, Bruvold WH: Vocational predictions compared with present vocational status of 60 young adults with cerebral palsy. Dev Med Child Neurol 1985, 27:775–784.

    Article  PubMed  CAS  Google Scholar 

  10. Pranzatelli MR: Oral pharmacology for the movement disorders of cerebral palsy. J Child Neurol 1996, 11(suppl 1):S13-S22.

    PubMed  Google Scholar 

  11. Russman BS, Tilton A, Gormley ME: Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment. Muscle Nerve Suppl 1997, 6:S181-S193.

    Article  PubMed  CAS  Google Scholar 

  12. Herrero BA, Ecklund AE, Street CS, et al.: Experimental botulism in monkeys: a clinical pathological study. Exp Mol Pathol 1967, 6:84–95.

    Article  PubMed  CAS  Google Scholar 

  13. Cosgrove AP, Graham HK: Botulinum toxin A prevents the development of contractures in the hereditary spastic mouse. Dev Med Child Neurol 1994, 36:379–385.

    Article  PubMed  CAS  Google Scholar 

  14. Cosgrove AP, Corry TS, Graham HK: Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994, 36:386–396.

    Article  PubMed  CAS  Google Scholar 

  15. Koman LA, Mooney IF III, Smith BP, et al.: Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop 1994, 14:299–303.

    PubMed  CAS  Google Scholar 

  16. Corry IS, Cosgrove AP, Duffy CM, et al.: Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomized prospective trial. J Pediatr Orthop 1998, 18:304–311. This is the first article to demonstrate the efficacy of botulinum toxin type A compared with another form of therapy. The research was limited in that it covered only a 3-month period. Longer-term studies are necessary to demonstrate the ultimate role of botulinum toxin type A in the management of cerebral palsy.

    Article  PubMed  CAS  Google Scholar 

  17. Corry IS, Cosgrove AP, Walsch EG, et al.: Botulinum toxin A in the hemiplegic limb: a double-blind trial. Dev Med Child Neurol 1997, 39:185–193.

    Article  PubMed  CAS  Google Scholar 

  18. Albright AL: Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 1996, 11(suppl 1):S29-S35.

    PubMed  Google Scholar 

  19. Armstrong RW, Steinbok P, Cochrane DD, et al.: Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 1997, 87:409–414. This report, although a level III study, nevertheless raises many issues about the efficacy of intrathecal baclofen as well the problems with its use in patients with cerebral palsy.

    PubMed  CAS  Google Scholar 

  20. Gerszten PC, Albright AL, Johnston GF: Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg 1998, 88:1009–1013.

    Article  PubMed  CAS  Google Scholar 

  21. Abbott R: Sensory rhizotomy for the treatment of childhood spasticity. J Child Neurol 1996, 11(suppl 1):S36-S42.

    PubMed  Google Scholar 

  22. Peter IC, Hoffman EB, Arens LJ.: Spondylolysis and spondylolisthesis after five-level lumbosacral laminectomy for selective posterior rhizotomy in cerebral palsy. Childs Nerv Syst 1993, 9:285–287.

    Article  PubMed  CAS  Google Scholar 

  23. Crawford K, Karol LA, Herring IA: Severe lumbar lordosis after dorsal rhizotomy. J Pediatr Orthop 1996, 16:336–339.

    PubMed  CAS  Google Scholar 

  24. Houle AM, Vernet O, Jednak R, et al.: Bladder function before and after selective rhizotomy in children with cerebral palsy. J Urol 1998, 160:1088–1091.

    Article  PubMed  CAS  Google Scholar 

  25. McLaughlin JF, Bjornson KF, Astley SJ, et al.: The role of selective dorsal rhizotomy in cerebral palsy: critical evaluation of a prospective clinical series. Dev Med Child Neurol 1994, 36:755–769.

    Article  PubMed  CAS  Google Scholar 

  26. Steinbok P, Reiner AM, Beauchamp R, et al.: A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy. Dev Med Child Neurol 1997, 39:178–184. This is the first of three articles published in 1997 and 1998 demonstrating the efficacy of selective dorsal rhizotomy compared with physical therapy. These three articles demonstrate the efficacy or lack of such of innovative therapeutic programs for cerebral palsy.

    Article  PubMed  CAS  Google Scholar 

  27. Russell D, Rosenbaum PL, Cadman D, et al.: The gross motor function measure: a means to evaluate the effects of physical therapy. Dev Med Child Neurol 1989, 31:341–352.

    Article  PubMed  CAS  Google Scholar 

  28. McLaughlin JF, Bkornson KF, Astley SJ, et al.: Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial. Dev Med Child Neurol 1998, 40:220–232. This is the second of three articles published in 1997 and 1998 comparing physical therapy with selective dorsal rhizotomy. This study showed that muscle tone was significantly decreased in the group undergoing selective dorsal rhizotomy but that there was no significant change in function between the groups.

    Article  PubMed  CAS  Google Scholar 

  29. Wright FV: Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled trial. Dev Med Child Neurol 1998, 40:239–247. This is the third study comparing selective dorsal rhizotomy (SDR) with physical therapy. Muscle tone was different in the two groups, and a significant functional change was found in the group underoing SDR. All three studies were reported after only 1 to 2 years of observation. The 5-year follow-up report will be extremely important in determining whether SDR will become a standard in the care of patients with cerebral palsy.

    Article  PubMed  CAS  Google Scholar 

  30. Chicoine MR, Park TS, Vogler GP, Kaufman BA: Predictors of ability to walk after selective dorsal rhizotomy in children with cerebral palsy. Neurosurgery 1996, 38:711–714.

    Article  PubMed  CAS  Google Scholar 

  31. Norlin R, Tkaczuk H: One-session surgery for correction of lower extremity deformities in children with cerebral palsy. J Pediatr Orthop 1985, 5:208–211.

    PubMed  CAS  Google Scholar 

  32. Watt JM, Robertson CMT, Grace MGA: Early prognosis for ambulation of neonatal intensive care survivors with cerebral palsy. Dev Med Child Neurol 1989, 31:766–773.

    Article  PubMed  CAS  Google Scholar 

  33. Rang M, Silver R, Garza I: Cerebral palsy. In Pediatric Orthopedics. Edited by Lovell WW, Winter RB.Philadelphia: J.B. Lippincott Co.; 1986.

    Google Scholar 

  34. Bleck EE: Orthopedic Management in Cerebral Palsy.Oxford: MacKeith Press; 1987.

    Google Scholar 

  35. Gage IR: Gait Analysis in Cerebral Palsy. Oxford: MacKeith Press; 1991.

    Google Scholar 

  36. Barry MJ: Physical therapy interventions for patients with movement disorders due to cerebral palsy. J Child Neurol 1996, 11(suppl 1):S51-S60.

    PubMed  Google Scholar 

  37. Palmer FB, Shapiro BK, Wachtel RC, et al.: The effects of physical therapy on cerebral palsy. A controlled trial in infants with spastic diplegia. N Engl J Med 1988, 318:803–808.

    Article  PubMed  CAS  Google Scholar 

  38. Breslau N, Staruch KS, Mortimer EA Jr: Psychological stress in mothers of disabled children. Am J Dis Child 1982, 136:682–686.

    PubMed  CAS  Google Scholar 

  39. Weindling AM, Hallam P, Gregg J, et al.: A randomized controlled trial of early physiotherapy for high-risk infants. Acta Pediatr 1996, 85:1107–1111. Patients assumed to be at risk for cerebral palsy based on an abnormal ultrasound of the brain were randomly subjected to early physical therapy. The methodology can serve other investigators who might be interested in studying the effect of early interventions.

    CAS  Google Scholar 

  40. Bower E, McLellan DE, Arney I, Campbell MI: A randomized controlled trial of different intensities of physiotherapy and different goal-setting procedures in 44 children with cerebral palsy. Dev Med Child Neurol 1996, 38:226–237. This is an example of how to study different therapies used in cerebral palsy, recognizing that no two patients are alike.

    Article  PubMed  CAS  Google Scholar 

  41. Pape KE, Kirsch SE, Galil A, et al.: Neuromuscular approach to the motor deficits of cerebral palsy: a pilot study. J Pediatr Orthop 1993, 13:628–633.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Neurology, Shriners Hospitals for Children, 3101 SW Sam Jackson Park Road, 97201, Portland, OR, USA

    Barry S. Russman MD

Authors
  1. Barry S. Russman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Russman, B.S. Cerebral palsy. Curr Treat Options Neurol 2, 97–107 (2000). https://doi.org/10.1007/s11940-000-0011-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-000-0011-4

Keywords

Search

Navigation